SOPHARMA AD (2/2022) Sales revenues for December 2021
Report no 2/2022
- 10.01.2022, 13:02
- Kategoria: Biznes i finanse
- Źródło: ESPI
Sopharma AD-BG11SOSOBT18-SOPHARMA
-
-
SOPHARMA AD (1/2022) Conclusion of transactions from the scope of art. 114, para. 2 of the LPOS
Report no 1/2022- 06.01.2022, 16:57
- Kategoria: Biznes i finanse
- Źródło: ESPI
-
SOPHARMA AD (203/2022) Notification from "Telso" AD under Art. 19 of Regulation (EU) No 596/2014 of 30 December 2021.
Report no 203/2022- 04.01.2022, 09:21
- Kategoria: Biznes i finanse
- Źródło: ESPI
-
SOPHARMA AD (201/2021) Notification from "Telso" AD under Art. 19 of Regulation (EU) No 596/2014 of 23 December 2021.
Report no 201/2021- 30.12.2021, 14:20
- Kategoria: Biznes i finanse
- Źródło: ESPI
-
SOPHARMA AD (200/2021) The subscription for the public offering of warrants is successfully comleted
Report no 200/2021- 30.12.2021, 13:45
- Kategoria: Biznes i finanse
- Źródło: ESPI
-
SOPHARMA AD (199/2021) Sale of the share in the capital of the subsidiary SIA "Briz"
Report no 199/2021- 23.12.2021, 16:06
- Kategoria: Biznes i finanse
- Źródło: ESPI
-
SOPHARMA AD (198/2021) Notification from "Telso" AD under Art. 19 of Regulation (EU) No 596/2014 of 22 December 2021.
Report no 198/2021- 23.12.2021, 12:52
- Kategoria: Biznes i finanse
- Źródło: ESPI
